Daniel Forsyth
Daniel Forsyth writes for Merja Review and other Independent Journal publications, covering M&A, activist stakes and investment banks and earnings and corporate announcements. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.
3 articles
13D Filing: Southport Sponsor Reports 27.7% of New SPAC
Southport Acquisition Sponsor II filed a Schedule 13D after the SPAC's Oct. 2 IPO, reporting 8.17 million shares, 27.7%, bought for $5.025 million. Key terms.
How activist investors work: stakes, demands, campaigns
How activist investors work: building a stake, Schedule 13D disclosure, private talks, shareholder proposals, board nominations and how campaigns usually end.
Schedule 13D: Definitive Healthcare Founder Flags Advent Buyout Bid
Jason Krantz switched to a Schedule 13D on Definitive Healthcare in September 2026 after Advent proposed a $1.02 per share deal requiring his equity rollover.